RCM
Rokos Capital Management Portfolio holdings
AUM
$5.98B
This Quarter Return
-0.63%
1 Year Return
+10.29%
3 Year Return
+29.47%
5 Year Return
+32.03%
10 Year Return
–
AUM
$993M
AUM Growth
+$993M
(-24%)
Cap. Flow
-$298M
Cap. Flow
% of AUM
-29.97%
Top 10 Holdings %
Top 10 Hldgs %
75.77%
Holding
80
New
13
Increased
6
Reduced
14
Closed
24
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$189M |
| 2 |
Elanco Animal Health
ELAN
|
$42.2M |
| 3 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$19.5M |
| 4 |
Intellia Therapeutics
NTLA
|
$18.4M |
| 5 |
New Fortress Energy
NFE
|
$16.8M |
Top Sells
| 1 |
Bank of America
BAC
|
$79.4M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
$60.5M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
$54.5M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$44M |
| 5 |
NVIDIA
NVDA
|
$40M |
Sector Composition
| 1 | Healthcare | 22.95% |
| 2 | Technology | 20.74% |
| 3 | Energy | 14.48% |
| 4 | Communication Services | 1.7% |
| 5 | Consumer Discretionary | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Invesco QQQ Trust
QQQ
$364B
| $192M | 8.42% | 727,607 +717,607 | +7,176% | +$189M |
|
2
Microsoft
MSFT
$3.77T
| $151M | 6.64% | 636,533 -25,970 | -4% | -$6.18M |
|
|
3
Energy Select Sector SPDR Fund
XLE
$27.6B
| $116M | 5.08% | 1,331,971 -505,223 | -27% | -$44M |
|
4
EQT Corp
EQT
$32.4B
| $66.1M | 2.9% | 1,958,995 -80,811 | -4% | -$2.73M |
|
|
SWN
5
DELISTED
Southwestern Energy Company
SWN
| $52.8M | 2.31% | 9,105,860 -10,445,728 | -53% | -$60.5M |
|
|
6
Elanco Animal Health
ELAN
$9.12B
| $48.8M | 2.14% | 4,019,540 +3,474,101 | +637% | +$42.2M |
|
|
7
Financial Select Sector SPDR Fund
XLF
$54.1B
| $40.8M | 1.79% | 1,192,942 -1,595,536 | -57% | -$54.5M |
|
|
EQRX
8
DELISTED
EQRx, Inc. Common Stock
EQRX
| $32.3M | 1.42% | 13,064,438 +7,868,044 | +151% | +$19.5M |
|
|
9
Intellia Therapeutics
NTLA
$1.22B
| $28.4M | 1.24% | 826,063 +535,535 | +184% | +$18.4M |
|
|
SPLK
10
DELISTED
Splunk Inc
SPLK
| $23.6M | 1.03% | 274,537 -59,248 | -18% | -$5.09M |
|
11
Royalty Pharma
RPRX
$15.6B
| $19.3M | 0.85% | 492,228 | – | – |
|
12
Zoetis
ZTS
$69.3B
| $18.1M | 0.79% | 124,052 | – | – |
|
13
Caribou Biosciences
CRBU
$174M
| $17.3M | 0.76% | 2,748,139 +840,630 | +44% | +$5.29M |
|
14
Alphabet (Google) Class C
GOOG
$2.58T
| $16.9M | 0.74% | 192,140 | – | – |
|
|
15
New Fortress Energy
NFE
$675M
| $16.8M | 0.74% | +400,000 | New | +$16.8M |
|
16
Cencora
COR
$56.5B
| $16.5M | 0.72% | +100,000 | New | +$16.5M |
|
17
Arrowhead Research
ARWR
$3.05B
| $16M | 0.7% | 400,922 | – | – |
|
18
PACCAR
PCAR
$52.5B
| $9.45M | 0.41% | +96,400 | New | +$9.45M |
|
19
Sangamo Therapeutics
SGMO
$157M
| $9.15M | 0.4% | 3,026,210 | – | – |
|
20
Amazon
AMZN
$2.44T
| $8.31M | 0.36% | +100,000 | New | +$8.31M |
|
21
Antero Resources
AR
$9.86B
| $8.06M | 0.35% | 263,533 | – | – |
|
22
PayPal
PYPL
$67.1B
| $7.63M | 0.33% | 108,300 | – | – |
|
23
Bausch Health
BHC
$2.74B
| $6.46M | 0.28% | 1,028,019 | – | – |
|
24
Bunge Global
BG
$16.8B
| $5.43M | 0.24% | 54,721 | – | – |
|
25
Alight
ALIT
$2.05B
| $5.21M | 0.23% | +625,000 | New | +$5.21M |
|